[{"会社名":"大正製薬(株)【4535】","証券コード":"4535","　":"前期","決算期":"2011年3月期","会計方式":"日本方式","決算発表日":"2011年5月13日","決算月数":"12か月","売上高":"268,632百万円","営業利益":"44,082百万円","経常利益":"54,077百万円","当期利益":"34,892百万円","EPS（一株当たり利益）":"124.90円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"1,901.74円","総資産":"618,434百万円","自己資本":"524,503百万円","資本金":"29,804百万円","有利子負債":"235百万円","自己資本比率":"84.8%","ROA（総資産利益率）":"5.70%","ROE（自己資本利益率）":"6.70%","総資産経常利益率":"8.83%"},{"会社名":"大正製薬(株)【4535】","証券コード":"4535","　":"2期前","決算期":"2010年3月期","会計方式":"日本方式","決算発表日":"2010年5月14日","決算月数":"12か月","売上高":"258,441百万円","営業利益":"34,686百万円","経常利益":"36,671百万円","当期利益":"19,485百万円","EPS（一株当たり利益）":"67.98円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"1,816.68円","総資産":"606,443百万円","自己資本":"517,550百万円","資本金":"29,804百万円","有利子負債":"1,275百万円","自己資本比率":"85.3%","ROA（総資産利益率）":"3.25%","ROE（自己資本利益率）":"3.81%","総資産経常利益率":"6.12%"},{"会社名":"大正製薬(株)【4535】","証券コード":"4535","　":"3期前","決算期":"2009年3月期","会計方式":"日本方式","決算発表日":"2009年5月15日","決算月数":"12か月","売上高":"256,213百万円","営業利益":"37,935百万円","経常利益":"39,902百万円","当期利益":"8,815百万円","EPS（一株当たり利益）":"30.01円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"1,745.96円","総資産":"591,568百万円","自己資本":"505,167百万円","資本金":"29,804百万円","有利子負債":"1,655百万円","自己資本比率":"85.4%","ROA（総資産利益率）":"1.45%","ROE（自己資本利益率）":"1.69%","総資産経常利益率":"6.55%"}]